Process Development Best Practices For CGT Commercialization Readiness

Dr. Behnam Ahmadian Baghbaderani, Global Head of Process Development for Cell & Gene Technologies, introduces some of the bioprocessing best practices required to de-risk the commercial manufacturing of cell and gene therapies.

In this webinar, learn:

• the principles of commercialization readiness, logical steps and the best practices to address them in process development
• FMEA (failure mode and effects analysis) and how to use it for commercialization readiness
• the best time to implement automation and minimize the commercialization risks
• the key requirements for analytical methods used in the commercial processes